Interview on SABC 2 (Fokus) with SAHPRA CEO on the termination of the Ivermectin Compassionate Use Programme

eNCA - Termination of the compassionate use programme for Ivermectin

Newzroom Afrika - COVID-19 home testing kit approval process

SAHPRA Industry workshop - 14 April 2022

Ms Mokgadi Fafudi discusses the problem of illicit medicines sold in Cape Town

Vaccine Safety Side Effects and Adverse Events Following Immunisation AEFIs Webinar

Concerns have again been raised about the safety of COVID-19 vaccines on social media - Prof Helen Rees

SAHPRA CEO discusses the approval of two new vaccines on SABC TV

SAHPRA CEO on full authorisation of two new vaccines

Newsroom Africka - SAHPRA CEO discusses approval of boosters

SAHPRA CEO discusses approval of Pfizer Booster on eNCA

Mitigating COVID 19 Vaccine Hesitancy in South Africa webinar

Enhancing the public trust in COVID-19 vaccination

SAHPRA CEO Responds to BFASA allegations Part 1

SAHPRA CEO Responds to BFASA on Newzroom Afrika Part 2

Topic: Adverse Events Following Immunization (AEFI"s)

SAHPRA CEO Spotlight on Sputnik V Vaccine

Self-reporting suspected adverse drug reactions ADRs of medicines and vaccines